Peer Review History: Fibroblast Growth Factor 23 (FGF23) is an Early Specific Marker in the Diagnosis and Staging of Chronic Kidney Disease (CKD) in Human

Editor(s):

(1) Dr. R. Deveswaran, M.S.Ramaiah University of Applied Sciences, India.

Reviewers:

(1) Kayhan Özkan, Turkey.

(2) Maria Mesquita, Université Libre De Bruxelles (ULB), Belgium.

Additional Reviewers:

 

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 7.8/10

Average Peer review marks at publication stage: 8.5/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Kayhan Özkan, Turkey) | File 1 | NA


Stage 2 | Peer review report_2 (Maria Mesquita, Belgium) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA